To test that hypothesis, CD45+ cells were isolated from MB49luc bladder tumors of control Ig– or NHS-muIL12–treated mice on day 5 after the final NHS-muIL12 treatment. The gene discussed is PTPRC; the disease is urinary bladder neoplasm.